Key Points
-
Calorie restriction (CR) is a dietary regimen, which has been shown to extend lifespan in a multitude of organisms. In addition, CR has been shown to reduce the incidence of age-related disorders (such as diabetes, cancer and cardiovascular disorders).
-
CR induces metabolic changes, improves insulin sensitivity and alters neuroendocrine functions in animals.
-
CR is a highly regulated process, which requires regulatory proteins that can sense food scarcity and mount an appropriate physiological response. The NAD-dependent deacetylase SIRT1 might link the energetics of cells to their lifespan.
-
CR has been shown to produce changes in the levels of hormones that are produced in the fat tissue (such as adiponectin, leptin, TNFα and resistin) that could mediate the beneficial effects of this regimen.
-
SIRT1 renders cells stress resistant by inhibiting the pro-apoptotic transcription factors p53 and forkhead. And, in white adipose tissue, SIRT1 has been shown to mobilize fat by repressing peroxisome proliferator-activated receptor (PPAR)γ.
-
CR has beneficial effects on glucose metabolism, and CR mice have lower glucose and insulin levels.
-
CR can protect against neurodegeneration in animal models of Huntington's disease, Alzheimer's disease, Parkinson's disease and stroke.
-
The levels of uncoupling proteins increase under CR and this might ameliorate the generation of oxidative damage by reducing reactive oxygen species and, thereby, slowing ageing.
Abstract
Calorie restriction (CR) is the only experimental manipulation that is known to extend the lifespan of a number of organisms including yeast, worms, flies, rodents and perhaps non-human primates. In addition, CR has been shown to reduce the incidence of age-related disorders (for example, diabetes, cancer and cardiovascular disorders) in mammals. The mechanisms through which this occurs have been unclear. CR induces metabolic changes, improves insulin sensitivity and alters neuroendocrine function in animals. In this review, we summarize recent findings that are beginning to clarify the mechanisms by which CR results in longevity and robust health, which might open new avenues of therapy for diseases of ageing.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Profiles of autophagy-related genes in esophageal adenocarcinoma
BMC Cancer Open Access 01 October 2020
-
MicroRNAs and obesity-induced endothelial dysfunction: key paradigms in molecular therapy
Cardiovascular Diabetology Open Access 09 September 2020
-
The role of the Acanthamoeba castellanii Sir2-like protein in the growth and encystation of Acanthamoeba
Parasites & Vectors Open Access 22 July 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout





References
McCay, C. M., Crowell, M. F. & Maynard, L. A. The effect of retarded growth upon the length of life span and upon the ultimate body size. J. Nutr. 10, 63–79 (1935).
Barrows, C. H. & Kokkonen, G. C. Dietary Restriction and Life Extension, Biological Mechanisms (ed. Moment, G. B.) (CRC Press Inc., Boca Raton, Florida, USA, 1982).
Lin, S. J., Defossez, P. A. & Guarente, L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289, 2126–2128 (2000).
Weindruch, R. & Walford, R. L. The Retardation of Aging and Disease by Dietary Restriction (ed. Thomas, C. C.) (Springfield, Illinois, USA, 1988). This book provides a comprehensive overview of the changes that occur during CR.
Barger, J. L., Walford, R. L. & Weindruch, R. The retardation of aging by caloric restriction: its significance in the transgenic era. Exp. Gerontol. 38, 1343–1351 (2003).
Ingram, D. K. et al. Development of calorie restriction mimetics as a prolongevity strategy. Ann. NY Acad. Sci. 1019, 412–423 (2004).
Roth, G. S. et al. Aging in rhesus monkeys: relevance to human health interventions. Science 305, 1423–1426 (2004). Research using non-human primates can provide a valuable tool for understanding the nature and causes of ageing processes that are observed in humans, as well as evaluating potential interventions.
Walford, R. L., Harris, S. B. & Gunion, M. W. The calorically restricted low-fat nutrient-dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol, and blood pressure in humans. Proc. Natl Acad. Sci. USA 89, 11533–11537 (1992).
Verdery, R. B. & Walford, R. L. Changes in plasma lipids and lipoproteins in humans during a 2-year period of dietary restriction in Biosphere 2. Arch. Intern. Med. 158, 900–906 (1998).
Walford, R. L., Mock, D., Verdery, R. & MacCallum, T. Calorie restriction in Biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. J. Gerontol. A Biol. Sci. Med. Sci. 57, B211–B224 (2002).
Heilbronn, L. K. & Ravussin, E. Calorie restriction and aging: review of the literature and implications for studies in humans. Am. J. Clin. Nutr. 78, 361–369 (2003).
Lee, C. K., Klopp, R. G., Weindruch, R. & Prolla, T. A. Gene expression profile of aging and its retardation by caloric restriction. Science 285, 1390–1393 (1999). Microarray analysis provides the most detailed description of the CR phenotype that is available so far.
Weindruch, R., Kayo, T., Lee, C. K. & Prolla, T. A. Microarray profiling of gene expression in aging and its alteration by caloric restriction in mice. J. Nutr. 131, 918S–923S (2001).
Weindruch, R., Kayo, T., Lee, C. K. & Prolla, T. A. Gene expression profiling of aging using DNA microarrays. Mech. Ageing Dev. 123, 177–193 (2002).
Hursting, S. D., Perkins, S. N., Phang, J. M. & Barrett, J. C. Diet and cancer prevention studies in p53-deficient mice. J. Nutr. 131, 3092S–3094S (2001).
Masoro, E. J. Caloric restriction and aging: an update. Exp. Gerontol. 35, 299–305 (2000).
Berrigan, D., Perkins, S. N., Haines, D. C. & Hursting, S. D. Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23, 817–822 (2002).
Lane, M. A., Ingram, D. K. & Roth, G. S. Calorie restriction in nonhuman primates: effects on diabetes and cardiovascular disease risk. Toxicol. Sci. 52, 41–48 (1999).
Stern, J. S., Gades, M. D., Wheeldon, C. M. & Borchers, A. T. Calorie restriction in obesity: prevention of kidney disease in rodents. J. Nutr. 131, 913S–917S (2001).
Anson, R. M. et al. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc. Natl Acad. Sci. USA 100, 6216–6220 (2003).
Mattson, M. P., Duan, W. & Guo, Z. Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J. Neurochem. 84, 417–431 (2003).
Harmon, D. Aging: a theory based on free radical and radiation chemistry. J. Nutr. 114, 411–417 (1956).
Sacher, G. A. Life Table Modifications and Life Prolongation (eds Finch, C. E. & Hayflick, L.) (Van Nostrand Rheinhold, New York, 1977).
Sohal, R. S. & Weindruch, R. Oxidative stress, caloric restriction, and aging. Science 273, 59–63 (1996).
Davies, K. J. Oxidative stress: the paradox of aerobic life. Biochem. Soc. Symp. 61, 1–31 (1995).
Fridovich, I. The biology of oxygen radicals. Science 201, 875–880 (1978).
Pryor, W. A. The formation of free radicals and the consequences of their reactions in vivo. Photochem. Photobiol. 28, 787–801 (1978).
Chance, B., Sies, H. & Boveris, A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527–605 (1979).
Raha, S. & Robinson, B. H. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem. Sci. 25, 502–508 (2000).
Droge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47–95 (2002).
Masoro, E. J., Yu, B. P. & Bertrand, H. A. Action of food restriction in delaying the aging process. Proc. Natl Acad. Sci. USA 79, 4239–4241 (1982). This paper dispels the notion that CR slows metabolism.
Lin, S. J. et al. Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature 418, 344–348 (2002). This paper shows that CR increases respiration in yeast to activate Sir2 and extend lifespan.
Houthoofd, K. et al. No reduction of metabolic rate in food restricted Caenorhabditis elegans. Exp. Gerontol. 37, 1359–1369 (2002).
Sinclair, D. A. & Guarente, L. Extrachromosomal rDNA circles — a cause of aging in yeast. Cell 91, 1033–1042 (1997).
Kaeberlein, M., McVey, M. & Guarente, L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13, 2570–2580 (1999).
Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795–800 (2000). This paper identifies the enzymatic activity of yeast and mammalian Sir2.
Landry, J. et al. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl Acad. Sci. USA 97, 5807–5811 (2000).
Smith, J. S. et al. A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc. Natl Acad. Sci. USA 97, 6658–6663 (2000).
Lin, S. J., Ford, E., Haigis, M., Liszt, G. & Guarente, L. Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev. 18, 12–16 (2004).
Anderson, R. M. et al. Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state NAD+ levels. J. Biol. Chem. 277, 18881–18890 (2002).
Kaeberlein, M., Kirkland, K. T., Fields, S. & Kennedy, B. K. Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol. 2, E296 (2004).
Tissenbaum, H. A. & Guarente, L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227–230 (2001).
Wood, J. G. et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686–689 (2004). This paper shows that the longevity induced by CR in D. melanogaster probably requires Sir2.
Motta, M. C. et al. Mammalian SIRT1 represses forkhead transcription factors. Cell 116, 551–563 (2004).
Vaziri, H. et al. hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase. Cell 107, 149–159 (2001).
Luo, J. et al. Negative control of p53 by Sir2α promotes cell survival under stress. Cell 107, 137–148 (2001).
Langley, E. et al. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21, 2383–2396 (2002).
Brunet, A. et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011–2015 (2004).
McBurney, M. W. et al. The mammalian SIR2α protein has a role in embryogenesis and gametogenesis. Mol. Cell. Biol. 23, 38–54 (2003).
Barzilai, N. & Gupta, G. Revisiting the role of fat mass in the life extension induced by caloric restriction. J. Gerontol. A Biol. Sci. Med. Sci. 54, B89–B96 (1999).
Feinstein, R., Kanety, H., Papa, M. Z., Lunenfeld, B. & Karasik, A. Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem. 268, 26055–26058 (1993).
Shuldiner, A. R., Yang, R. & Gong, D. W. Resistin, obesity and insulin resistance — the emerging role of the adipocyte as an endocrine organ. N. Engl. J. Med. 345, 1345–1346 (2001).
Ukkola, O. Resistin — a mediator of obesity-associated insulin resistance or an innocent bystander? Eur. J. Endocrinol. 147, 571–574 (2002).
Stephens, J. M., Lee, J. & Pilch, P. F. Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem. 272, 971–976 (1997).
Uysal, K. T., Wiesbrock, S. M. & Hotamisligil, G. S. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-α-mediated insulin resistance in genetic obesity. Endocrinology 139, 4832–4838 (1998).
Uysal, K. T., Wiesbrock, S. M., Marino, M. W. & Hotamisligil, G. S. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389, 610–614 (1997).
Kim, H. J., Kim, K. W., Yu, B. P. & Chung, H. Y. The effect of age on cyclooxygenase-2 gene expression: NF-κB activation and IκBα degradation. Free Radic. Biol. Med. 28, 683–692 (2000).
Yao, J., Mackman, N., Edgington, T. S. & Fan, S. T. Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-κB transcription factors. J. Biol. Chem. 272, 17795–17801 (1997).
Yeung, F. et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369–2380 (2004).
Steppan, C. M. et al. The hormone resistin links obesity to diabetes. Nature 409, 307–312 (2001).
Wolfe, B. E., Jimerson, D. C., Orlova, C. & Mantzoros, C. S. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin. Endocrinol. (Oxf) 61, 332–338 (2004).
Meier, U. & Gressner, A. M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin. Chem. 50, 1511–1525 (2004).
Legradi, G., Emerson, C. H., Ahima, R. S., Flier, J. S. & Lechan, R. M. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 138, 2569–2576 (1997).
Allison, D. B. et al. Genetic variability in responses to caloric restriction in animals and in regulation of metabolism and obesity in humans. J. Gerontol. A Biol. Sci. Med. Sci. 56, 55–65 (2001).
Pajvani, U. B. & Scherer, P. E. Adiponectin: systemic contributor to insulin sensitivity. Curr. Diab. Rep. 3, 207–213 (2003).
Wu, X. et al. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52, 1355–1363 (2003).
Musi, N. et al. AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 280, E677–E684 (2001).
Combs, T. P. et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52, 268–276 (2003).
Bertrand, H. A., Lynd, F. T., Masoro, E. J. & Yu, B. P. Changes in adipose mass and cellularity through the adult life of rats fed ad libitum or a life-prolonging restricted diet. J. Gerontol. 35, 827–835 (1980).
Harrison, D. E., Archer, J. R. & Astle, C. M. Effects of food restriction on aging: separation of food intake and adiposity. Proc. Natl Acad. Sci. USA 81, 1835–1838 (1984).
Bluher, M., Kahn, B. B. & Kahn, C. R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299, 572–574 (2003).
Chiu, C. H., Lin, W. D., Huang, S. Y. & Lee, Y. H. Effect of a C/EBP gene replacement on mitochondrial biogenesis in fat cells. Genes Dev. 18, 1970–1975 (2004).
Klein, S. et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N. Engl. J. Med. 350, 2549–2557 (2004).
Kissebah, A. H. Insulin resistance in visceral obesity. Int. J. Obes. 15 (Suppl. 2), 109–115 (1991).
Bjorntorp, P. Metabolic implications of body fat distribution. Diabetes Care 14, 1132–1143 (1991).
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. & Spiegelman, B. M. mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224–1234 (1994).
Picard, F. et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 429, 771–776 (2004). This paper links the function of mammalian SIRT1 to the regulation of fat storage in white adipocytes.
Nemoto, S., Fergusson, M. M. & Finkel, T. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306, 2105–2108 (2004).
Cohen, H. Y. et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390–392 (2004).
Corpas, E., Harman, S. M. & Blackman, M. R. Human growth hormone and human aging. Endocr. Rev. 14, 20–39 (1993).
Carlson, H. E., Gillin, J. C., Gorden, P. & Snyder, F. Absence of sleep-related growth hormone peaks in aged normal subjects and in acromegaly. J. Clin. Endocrinol. Metab. 34, 1102–1105 (1972).
Rudman, D. et al. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J. Clin. Invest. 67, 1361–1369 (1981).
Lieberman, S. A., Mitchell, A. M., Marcus, R., Hintz, R. L. & Hoffman, A. R. The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement therapy. Horm. Metab. Res. 26, 229–233 (1994).
Chang, A. M. & Halter, J. B. Aging and insulin secretion. Am. J. Physiol. Endocrinol. Metab. 284, E7–E12 (2003).
Kimura, K. D., Tissenbaum, H. A., Liu, Y. & Ruvkun, G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277, 942–946 (1997).
Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. A C. elegans mutant that lives twice as long as wild type. Nature 366, 461–464 (1993).
Dhahbi, J. M. et al. Caloric restriction alters the feeding response of key metabolic enzyme genes. Mech. Ageing Dev. 122, 1033–1048 (2001).
Barzilai, N., Banerjee, S., Hawkins, M., Chen, W. & Rossetti, L. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J. Clin. Invest. 101, 1353–1361 (1998).
Gupta, G. et al. Ability of insulin to modulate hepatic glucose production in aging rats is impaired by fat accumulation. Am. J. Physiol. Endocrinol. Metab. 278, E985–E991 (2000).
Spindler, S. R. Calorie restriction enhances the expression of key metabolic enzymes associated with protein renewal during aging. Ann. NY Acad. Sci. 928, 296–304 (2001).
Weindruch, R. & Prolla, T. A. Gene expression profile of the aging brain. Arch. Neurol. 59, 1712–1714 (2002).
Lunn, E. R., Perry, V. H., Brown, M. C., Rosen, H. & Gordon, S. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci. 1, 27–33 (1989).
Araki, T., Sasaki, Y. & Milbrandt, J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 1010–1013 (2004).
Jacobsson, A., Stadler, U., Glotzer, M. A. & Kozak, L. P. Mitochondrial uncoupling protein from mouse brown fat. Molecular cloning, genetic mapping, and mRNA expression. J. Biol. Chem. 260, 16250–16254 (1985).
Bouillaud, F., Ricquier, D., Thibault, J. & Weissenbach, J. Molecular approach to thermogenesis in brown adipose tissue: cDNA cloning of the mitochondrial uncoupling protein. Proc. Natl Acad. Sci. USA 82, 445–448 (1985).
Ricquier, D. & Bouillaud, F. The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem. J. 345, 161–179 (2000).
Ricquier, D. & Bouillaud, F. Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance. J. Physiol. 529, 3–10 (2000).
Dulloo, A. G. & Samec, S. Uncoupling proteins: their roles in adaptive thermogenesis and substrate metabolism reconsidered. Br. J. Nutr. 86, 123–139 (2001).
Arsenijevic, D. et al. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nature Genet. 26, 435–439 (2000).
Boss, O. et al. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett. 408, 39–42 (1997).
Mao, W. et al. UCP4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells. FEBS Lett. 443, 326–330 (1999).
Yu, X. X. et al. Characterization of novel UCP5/BMCP1 isoforms and differential regulation of UCP4 and UCP5 expression through dietary or temperature manipulation. FASEB J. 14, 1611–1618 (2000).
Yang, X., Pratley, R. E., Tokraks, S., Tataranni, P. A. & Permana, P. A. UCP5/BMCP1 transcript isoforms in human skeletal muscle: relationship of the short-insert isoform with lipid oxidation and resting metabolic rates. Mol. Genet. Metab. 75, 369–373 (2002).
Sanchis, D. et al. BMCP1, a novel mitochondrial carrier with high expression in the central nervous system of humans and rodents, and respiration uncoupling activity in recombinant yeast. J. Biol. Chem. 273, 34611–34615 (1998).
Vidal-Puig, A. J. et al. Energy metabolism in uncoupling protein 3 gene knockout mice. J. Biol. Chem. 275, 16258–16266 (2000).
Gong, D. W. et al. Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J. Biol. Chem. 275, 16251–16257 (2000).
Speakman, J. R. et al. Uncoupled and surviving: individual mice with high metabolism have greater mitochondrial uncoupling and live longer. Aging Cell 3, 87–95 (2004). This paper shows a correlation between metabolic rate and lifespan due to uncoupling.
Pecqueur, C. et al. Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J. Biol. Chem. 276, 8705–8712 (2001).
Xiao, H., Massaro, D., Massaro, G. D. & Clerch, L. B. Expression of lung uncoupling protein-2 mRNA is modulated developmentally and by caloric intake. Exp. Biol. Med. (Maywood) 229, 479–485 (2004).
Reilly, J. M. & Thompson, M. P. Dietary fatty acids up-regulate the expression of UCP2 in 3T3-L1 preadipocytes. Biochem. Biophys. Res. Commun. 277, 541–545 (2000).
Samec, S., Seydoux, J. & Dulloo, A. G. Post-starvation gene expression of skeletal muscle uncoupling protein 2 and uncoupling protein 3 in response to dietary fat levels and fatty acid composition: a link with insulin resistance. Diabetes 48, 436–441 (1999).
Gong, D. W., He, Y. & Reitman, M. L. Genomic organization and regulation by dietary fat of the uncoupling protein 3 and 2 genes. Biochem. Biophys. Res. Commun. 256, 27–32 (1999).
Samec, S., Seydoux, J. & Dulloo, A. G. Interorgan signaling between adipose tissue metabolism and skeletal muscle uncoupling protein homologs: is there a role for circulating free fatty acids? Diabetes 47, 1693–1698 (1998).
Dean, D. J., Gazdag, A. C., Wetter, T. J. & Cartee, G. D. Comparison of the effects of 20 days and 15 months of calorie restriction on male Fischer 344 rats. Aging (Milano) 10, 303–307 (1998).
Samec, S., Seydoux, J. & Dulloo, A. G. Role of UCP homologues in skeletal muscles and brown adipose tissue: mediators of thermogenesis or regulators of lipids as fuel substrate? FASEB J. 12, 715–724 (1998).
Cadenas, S. et al. UCP2 and UCP3 rise in starved rat skeletal muscle but mitochondrial proton conductance is unchanged. FEBS Lett. 462, 257–260 (1999).
Rousset, S. et al. The biology of mitochondrial uncoupling proteins. Diabetes 53 (Suppl. 1), S130–S135 (2004).
Acknowledgements
We thank members of the Guarente laboratory for editorial comments and apologize to those whose work was not cited due to space limitations. The work in the Guarente laboratory was supported by grants from the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Leonard Guarente is founder, stockholder and consultant for Elixin Pharmaceuticals.
Glossary
- REACTIVE OXYGEN SPECIES
-
(ROS). A reactive intermediate oxygen species that usually contains an unpaired electron in its outermost shell of electrons. Examples include: superoxide anion (O2•−), hydroxyl radical (OH•), hydroxyl ion (OH−), hydrogen peroxide (H2O2) and hypochlorite ion (OCl−).
- ELECTRON-TRANSPORT CHAIN
-
The electron-transport chain comprises complexes I–IV and an ATPase, which couples the transfer of an electron from NADH or FADH to molecular oxygen (O2). This process pumps protons (H+) across the mitochondrial membrane, which generates a proton gradient, the energy of which drives ATP synthesis by the ATPase.
- HISTONE DEACETYLASE
-
An enzyme and chromatin-remodelling factor that deacetylates histone proteins. Because deacetylation is energetically favoured, the class-I and -II deacetylases do not require any cofactors, such as ATP or NAD. However, the Sir2 class-III histone deacetylase uses NAD as a co-substrate.
- NICOTINAMIDE
-
One of the cleavage products of nicotinamide adenine dinucleotide (NAD) that is produced in each deacetylation cycle (along with acetyl-ADP-ribose). It is also a non-competitive inhibitor of Sir2 deacetylases.
- SIRTUIN
-
A protein that has sequence homology to the conserved enzymatic domain of yeast Sir2. In mammals, there are seven sirtuins, SIRT1–7.
- FORKHEAD TRANSCRIPTION FACTOR
-
A member of a conserved family of transcription factors. Forkhead transcription factors belong to the winged-helix class of DNA-binding proteins. They function as key regulators of stress resistance and metabolism in mammals and of lifespan in C. elegans.
- WHITE ADIPOSE TISSUE
-
(WAT). A depot of specialized cells that function as the main storage site for fat in the form of triglycerides. WAT has different functions, such as a heat insulator, a mechanical cushion and, most importantly, a source of energy. Also, WAT has been found to produce hormones, the levels of which are regulated by the amount of stored fat.
- HYPERINSULINAEMIA
-
A state of abnormally high levels of insulin in the blood. One cause of hyper-insulinaemia is high insulin production by pancreatic β-cells to compensate for insulin resistance in peripheral tissues.
- HYPERGLYCAEMIA
-
A state of high levels of glucose in the blood. Hyperglycaemia is usually an early sign of insulin resistance, which can lead to diabetes mellitus.
- WALLERIAN STRAIN OF MICE
-
A strain of mice that carries a spontaneous dominant mutation in the Wld locus that stabilizes the axons of peripheral neurons from degeneration after neuronal damage. The Wld locus is at a translocation that fuses the gene encoding ubiquitin fusion degradation protein 2a (UFD2a), a ubiquitin-chain-assembly factor, to the complete sequence of the nicotinamide mononucleotide adenyl-transferase-1 (Nmnat1) gene. The resulting increase in NMNAT1 expression causes the phenotype.
- UNCOUPLING PROTEINS
-
(UCPs). A family of mitochondrial-inner-membrane proteins. They allow the leakage of protons down the electrochemical gradient that is generated by respiration, thereby uncoupling oxygen consumption and ATP synthesis from the production of chemical energy.
- BROWN ADIPOSE TISSUE
-
A depot of fat cells that is used for thermogenesis in rodents, brown adipose tissue derives its colour from rich vascularization and densely packed mitochondria; these properties reflect its high metabolism of fat in response to cold exposure.
Rights and permissions
About this article
Cite this article
Bordone, L., Guarente, L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 6, 298–305 (2005). https://doi.org/10.1038/nrm1616
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrm1616
This article is cited by
-
Upregulation of SIRT1 Contributes to dmPGE2-dependent Radioprotection of Hematopoietic Stem Cells
Stem Cell Reviews and Reports (2022)
-
The macrophage senescence hypothesis: the role of poor heat shock response in pulmonary inflammation and endothelial dysfunction following chronic exposure to air pollution
Inflammation Research (2022)
-
Calorie restriction delays cardiac senescence and improves cardiac function in obese diabetic rats
Molecular and Cellular Biochemistry (2021)
-
Sirtuins and the circadian clock interplay in cardioprotection: focus on sirtuin 1
Cellular and Molecular Life Sciences (2021)
-
The role of the Acanthamoeba castellanii Sir2-like protein in the growth and encystation of Acanthamoeba
Parasites & Vectors (2020)